NCT05880823

Brief Summary

This is a real world data collection observational study at a single site. There are both prospective and retrospective cohorts. The study will examine the safety and effectiveness of the Synergy cervical disc system in patients with degenerative cervical disc disease.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 30, 2023

Completed
11 months until next milestone

Study Start

First participant enrolled

April 15, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2026

Completed
Last Updated

May 7, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

April 24, 2023

Last Update Submit

April 30, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Neck Disability Index (NDI)

    Neck disability Index improvement of \>15 pts (out of 100) in subjects by 12 months post operative compared with baseline. A lower score is a better score.

    12 months

  • Device Related or Device Procedure Related Adverse Events

    Absence of major device related adverse events defined as radiographic failure, neurologic failure or failure by adverse event

    12 months

Secondary Outcomes (5)

  • Neck and Arm Pain Measurement

    pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month

  • Patient Satisfaction

    6 week, 3 month, 6 month, 12 month, 24 month

  • Motor and Sensory Function in the Arm

    pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month

  • Nurick's Criteria

    pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month

  • Odom's criteria

    6 week, 3 month, 6 month, 12 month, 24 month

Study Arms (2)

Prospective

All patients for whom the decision has been made to have the Synergy Disc system implanted and give informed consent will be enrolled in this study, following country-specific requirements.

Device: Synergy cervical disc system

Retrospective

Patients who have previously received the Synergy Disc system in the last ten years are eligible for inclusion in the retrospective data collection; a waiver of consent, or an informed consent, for the retrospective data collection from the medical records of the implanting surgeon will be sought per country-specific regulations.

Device: Synergy cervical disc system

Interventions

motion preservation disc

ProspectiveRetrospective

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The patients for this study will be recruited from the physician's practice.

You may qualify if:

  • Age 21 or above at the time of the surgery.
  • Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted
  • Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy
  • Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression:
  • herniated disc and/or osteophyte formation
  • Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.)
  • Failed a minimum of 6 weeks conservative treatment
  • Written informed consent given by subject.

You may not qualify if:

  • Moderate to advanced spondylosis
  • Diagnosis of osteoporosis
  • Active systemic infection or infection at the operative site
  • Pregnancy
  • Marked cervical instability on lateral, coronal, or flexion/extension radiographs
  • Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level
  • Severe pathology of the facet joints of the involved vertebral bodies
  • Previous diagnosis of osteopenia or osteomalacia
  • More than one immobile vertebral level between C1 and T1 from any cause
  • Morbid obesity
  • Vulnerable person (pregnant patients, emergency cases, children, prisoners and people without mental capacity)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neurochirurgie am Gasteig

Munich, Bavaria, 81669, Germany

Location

Study Officials

  • Jane M Jacob, PhD

    Synergy Spine Solutions

    STUDY DIRECTOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2023

First Posted

May 30, 2023

Study Start

April 15, 2024

Primary Completion

April 15, 2026

Study Completion

April 15, 2026

Last Updated

May 7, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations